Explore 3 Stock Ideas & Industry Insights Download Free Report

Healthcare

Why Doximity (NYSE:DOCS) Climbed After Touting a Top Benchmark Result for Its AI Assistant

● Doximity Ask led US-based models in the NOHARM benchmark.

Nitish Kishor | 12 October 2026

Elevance Health (NYSE:ELV) Stock Draws Attention on the S&P 500 as 2027 Medicare Star Ratings Land

● Elevance Health was among the managed-care stocks in focus on Friday after the 2027MedicareAdvantage Star Ratings were released.

Nitish Kishor | 12 October 2026

Gilead Sciences (NASDAQ:GILD) Stock: Why It Climbed on the S&P 500 as Health Care Led the Gainers

● Gilead Sciences climbed on Friday as health care ranked among the S&P 500's two best sectors, with no company news.

Nitish Kishor | 12 October 2026

Why Ginkgo Bioworks (NYSE:DNA) Soared as It Opened Its Autonomous Lab to an NSF Program

● It will give in-kind access to its autonomous Boston lab.

Nitish Kishor | 12 October 2026

Why Humana (NYSE:HUM) Soared on the S&P 500 as New Star Ratings Put Nearly All Members in Top Plans

● New 2027MedicareAdvantage star ratings put nearly all Humana members in plans rated four stars or higher.

Nitish Kishor | 12 October 2026

Humana (NYSE:HUM) Stock Jumps on the S&P 500 as a Restored Four-Star Contract Draws Higher Targets

● CMS restored Humana's largest contract, H5216, to four stars from three and a half in the 2027 ratings.

Nitish Kishor | 12 October 2026

Why Brookdale Senior Living (NYSE:BKD) Slid With No Company Announcement

● No announcement, filing or analyst action explained the move.

Nitish Kishor | 12 October 2026

Centene (NYSE:CNC): How Fewer Members in Top-Rated Plans Put It in the Spotlight on the S&P 500

● Centene came into focus on Friday after 2027MedicareAdvantage Star Ratings showed fewer members in four-star-or-better plans.

Nitish Kishor | 12 October 2026
Support

Hi! How can we help you today?

Loading…